• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Immunity . Low-Avidity CD4 + T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19

tetano

Editor, Senior Moderator
Immunity


. 2020 Nov 26;S1074-7613(20)30503-3.
doi: 10.1016/j.immuni.2020.11.016. Online ahead of print.
Low-Avidity CD4 [SUP]+[/SUP] T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19


Petra Bacher[SUP] 1 [/SUP], Elisa Rosati[SUP] 2 [/SUP], Daniela Esser[SUP] 3 [/SUP], Gabriela Rios Martini[SUP] 4 [/SUP], Carina Saggau[SUP] 5 [/SUP], Esther Schiminsky[SUP] 5 [/SUP], Justina Dargvainiene[SUP] 3 [/SUP], Ina Schr?der[SUP] 3 [/SUP], Imke Wieters[SUP] 6 [/SUP], Yascha Khodamoradi[SUP] 6 [/SUP], Fabian Eberhardt[SUP] 6 [/SUP], Maria J G T Vehreschild[SUP] 6 [/SUP], Holger Neb[SUP] 7 [/SUP], Michael Sonntagbauer[SUP] 7 [/SUP], Claudio Conrad[SUP] 8 [/SUP], Florian Tran[SUP] 9 [/SUP], Philip Rosenstiel[SUP] 2 [/SUP], Robert Markewitz[SUP] 3 [/SUP], Klaus-Peter Wandinger[SUP] 3 [/SUP], Max Augustin[SUP] 10 [/SUP], Jan Rybniker[SUP] 10 [/SUP], Matthias Kochanek[SUP] 11 [/SUP], Frank Leypoldt[SUP] 12 [/SUP], Oliver A Cornely[SUP] 13 [/SUP], Philipp Koehler[SUP] 14 [/SUP], Andre Franke[SUP] 2 [/SUP], Alexander Scheffold[SUP] 5 [/SUP]



Affiliations

Abstract

CD4[SUP]+[/SUP] T cells reactive against SARS-CoV-2 can be found in unexposed individuals, and these are suggested to arise in response to common cold coronavirus (CCCoV) infection. Here, we utilized SARS-CoV-2-reactive CD4[SUP]+[/SUP] T cell enrichment to examine the antigen avidity and clonality of these cells, as well as the relative contribution of CCCoV cross-reactivity. SARS-CoV-2-reactive CD4[SUP]+[/SUP] memory T cells were present in virtually all unexposed individuals examined, displaying low functional avidity and multiple, highly variable cross-reactivities that were not restricted to CCCoVs. SARS-CoV-2-reactive CD4[SUP]+[/SUP] T cells from COVID-19 patients lacked cross-reactivity to CCCoVs, irrespective of strong memory T cell responses against CCCoV in all donors analyzed. In severe but not mild COVID-19, SARS-CoV-2-specific T cells displayed low functional avidity and clonality, despite increased frequencies. Our findings identify low-avidity CD4[SUP]+[/SUP] T cell responses as a hallmark of severe COVID-19 and argue against a protective role for CCCoV-reactive T cells in SARS-CoV-2 infection.

Keywords: ARTE; COVID-19; SARS-CoV-2; T cell cross-reactivity; antigen-reactive T cell enrichment; antigen-specific T cells; common cold coronavirus; human coronavirus; pre-existing memory.
 
Back
Top Bottom